Literature DB >> 16754512

Comparison of fetal and adult marrow stromal cells in osteogenesis with and without glucocorticoids.

Pi-Ling Chang1, Harry C Blair, Xiaochu Zhao, Yi-wen Chien, Dungtsa Chen, Arabella B Tilden, Zhijie Chang, Xu Cao, Ona Marie Faye-Petersen, Patricia Hicks.   

Abstract

To better understand the potential use of fetal marrow stromal cells (MSCs) in bone tissue engineering, we compared the ability of these cells with those of adult MSCs with respect to osteoblasts differentiation in the presence or absence of glucocorticoids. Cells were grown for 3-4 weeks in basal medium or supplemented with 100 nM dexamethasone (DEX, a synthetic glucocorticoid analog) or with 50 microM L-ascorbate and 10 mM glycerol-2-phosphate (AS+GP) or with AS+GP+DEX. At various time points in culture, the following parameters were compared between fetal and adult MSCs: cell morphology, cell proliferation, alkaline phosphatase activity, calcium (45Ca) uptake, von Kossa staining, and glucocorticoids receptor expression were analyzed. Compared with adult MSCs, fetal cells showed a less dramatic change to cuboidal morphology in DEX-containing media. Fetal MSCs in all media conditions showed higher proliferation rates and lower alkaline phosphatase activities (p < 0.001) than adult cells. Both fetal and adult MSCs responded similarly in DEX-containing media with respect to suppressing cell proliferation, stimulating alkaline phosphatase activity, and consistently accumulating calcium (usually higher in fetal cells) with subsequent formation of mineralized matrix when compared with cells cultured in AS+GP. Our findings further implicate the requirement of glucocorticoids in osteogenesis. In conclusion, compared with adult MSCs, fetal cells showed greater ability in sustaining cell proliferation and calcium uptake suggesting that they may be useful for bone tissue repair.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16754512     DOI: 10.1080/03008200600584074

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  13 in total

1.  Adrenocorticotropic hormone and 1,25-dihydroxyvitamin D3 enhance human osteogenesis in vitro by synergistically accelerating the expression of bone-specific genes.

Authors:  Irina L Tourkova; Li Liu; Nareerat Sutjarit; Quitterie C Larrouture; Jianhua Luo; Lisa J Robinson; Harry C Blair
Journal:  Lab Invest       Date:  2017-07-24       Impact factor: 5.662

2.  Osteoblast Differentiation and Bone Matrix Formation In Vivo and In Vitro.

Authors:  Harry C Blair; Quitterie C Larrouture; Yanan Li; Hang Lin; Donna Beer-Stoltz; Li Liu; Rocky S Tuan; Lisa J Robinson; Paul H Schlesinger; Deborah J Nelson
Journal:  Tissue Eng Part B Rev       Date:  2016-12-27       Impact factor: 6.389

Review 3.  Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord.

Authors:  Cun-Gang Fan; Qing-jun Zhang; Jing-ru Zhou
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

4.  Follicle stimulating hormone receptor in mesenchymal stem cells integrates effects of glycoprotein reproductive hormones.

Authors:  Irina L Tourkova; Michelle R Witt; La Li; Quitterie Larrouture; Li Liu; Jianhua Luo; Lisa J Robinson; Harry C Blair
Journal:  Ann N Y Acad Sci       Date:  2014-08-12       Impact factor: 5.691

5.  Concise Review: In Vitro Formation of Bone-Like Nodules Sheds Light on the Application of Stem Cells for Bone Regeneration.

Authors:  Saad Mechiche Alami; Sophie C Gangloff; Dominique Laurent-Maquin; Yun Wang; Halima Kerdjoudj
Journal:  Stem Cells Transl Med       Date:  2016-07-25       Impact factor: 6.940

6.  ACTH protects against glucocorticoid-induced osteonecrosis of bone.

Authors:  Mone Zaidi; Li Sun; Lisa J Robinson; Irina L Tourkova; Li Liu; Yujuan Wang; Ling-Ling Zhu; Xuan Liu; Jianhua Li; Yuanzhen Peng; Guozhe Yang; Xingming Shi; Alice Levine; Jameel Iqbal; Beatrice B Yaroslavskiy; Carlos Isales; Harry C Blair
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

7.  Characterization and comparison of osteoblasts derived from mouse embryonic stem cells and induced pluripotent stem cells.

Authors:  Ming-San Ma; Vishnu Kannan; Anneriek E de Vries; Marcin Czepiel; Evelyn M Wesseling; Veerakumar Balasubramaniyan; Roel Kuijer; Arjan Vissink; Sjef C V M Copray; Gerry M Raghoebar
Journal:  J Bone Miner Metab       Date:  2016-01-08       Impact factor: 2.626

8.  Age-related changes in the osteogenic differentiation potential of mouse bone marrow stromal cells.

Authors:  Weixi Zhang; Guomin Ou; Mark Hamrick; William Hill; James Borke; Karl Wenger; Norman Chutkan; Jack Yu; Qing-Sheng Mi; Carlos M Isales; Xing-Ming Shi
Journal:  J Bone Miner Res       Date:  2008-07       Impact factor: 6.741

9.  The Phosphate Source Influences Gene Expression and Quality of Mineralization during In Vitro Osteogenic Differentiation of Human Mesenchymal Stem Cells.

Authors:  Luisa M Schäck; Sandra Noack; Ramona Winkler; Gesa Wißmann; Peter Behrens; Mathias Wellmann; Michael Jagodzinski; Christian Krettek; Andrea Hoffmann
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

10.  Safety and Efficacy of Human Wharton's Jelly-Derived Mesenchymal Stem Cells Therapy for Retinal Degeneration.

Authors:  S N Leow; Chi D Luu; M H Hairul Nizam; P L Mok; R Ruhaslizan; H S Wong; Wan Haslina Wan Abdul Halim; M H Ng; B H I Ruszymah; S R Chowdhury; M L C Bastion; K Y Then
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.